REGENXBIO Inc. Business Finance Contracts & Agreements

10 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Pre-funded Warrant
Warrant Agreements
REGENXBIO Inc.
Biotechnology
NY
2024
Underwriting Agreement, dated March 6, 2024, among REGENXBIO Inc. and Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, Barclays Capital Inc. and Stifel, Nicolaus & Company,...
Underwriting Agreements
REGENXBIO Inc.
Biotechnology
NY
2024
Royalty Purchase Agreement dated December 22, 2020 between the Registrant and entities managed by Healthcare Royalty Management, LLC
Purchase Agreements
REGENXBIO Inc.
Biotechnology
NY
2021
Underwriting Agreement, dated January 7, 2021, among REGENXBIO Inc. and BofA Securities, Inc., Morgan Stanley & Co. LLC and Barclays Capital Inc., as representatives of the...
Underwriting Agreements
REGENXBIO Inc.
Biotechnology
NY
2021
Underwriting Agreement, dated August 9, 2018, among REGENXBIO Inc. and Morgan Stanley & Co. LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and Barclays Capital Inc., as...
Underwriting Agreements
REGENXBIO Inc.
Biotechnology
NY
2018
3,700,000 Shares REGENXBIO INC. COMMONSTOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENT
Underwriting Agreements
REGENXBIO Inc.
Biotechnology
NY
2017
REGENXBIO INC. 2015 EMPLOYEE STOCK PURCHASE PLAN (AS ADOPTED ON JUNE 17, 2015) REGENXBIO INC. 2015 EMPLOYEE STOCK PURCHASE PLAN
Stock Agreements
REGENXBIO Inc.
Biotechnology
DE
2015
[ ] Shares REGENXBIO INC. COMMONSTOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENT
Underwriting Agreements
REGENXBIO Inc.
Biotechnology
NY
2015
REGENXBIO INC. 2015 EMPLOYEE STOCK PURCHASE PLAN (AS ADOPTED ON JUNE 17, 2015) REGENXBIO INC. 2015 EMPLOYEE STOCK PURCHASE PLAN
Stock Agreements
REGENXBIO Inc.
Biotechnology
DE
2015
AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT
Investor Rights Agreements
REGENXBIO Inc.
Biotechnology
DE
2015